ΣΥΡΙΓΓΑ

Η παρούσα εφεύρεση αναφέρεται σε μια σύριγγα, συγκεκριμένα σε μια σύριγγα μικρού όγκου, όπως μια σύριγγα κατάλληλη για οφθαλμικές ενέσεις. The syringe (1) has a stopper arranged within a body (2) such that a front surface of the stopper and the body define a variable volume chamber from which a flui...

Full description

Saved in:
Bibliographic Details
Main Authors BUETTGEN, Heinrich Martin, BRYANT, Andrew Mark, ROYER, Christophe, PICCI, Marie, SIGG, Juergen
Format Patent
LanguageGreek
Published 29.05.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Η παρούσα εφεύρεση αναφέρεται σε μια σύριγγα, συγκεκριμένα σε μια σύριγγα μικρού όγκου, όπως μια σύριγγα κατάλληλη για οφθαλμικές ενέσεις. The syringe (1) has a stopper arranged within a body (2) such that a front surface of the stopper and the body define a variable volume chamber from which a fluid is expelled though an outlet of the body, and a backstop (6) including two finger projections. A plunger (4) comprises a plunger contact surface to contact the stopper such that the plunger forces the stopper towards an outlet end. The syringe is filled with a vascular endothelial growth factor (VEGF) antagonist fluid of about 0.15-0.175 ml containing a non-antibody VEGF antagonist aflibercept at a concentration of 40 mg/ml. The syringe comprises a syringe barrel filled with silicone oil of 100 microgram.
Bibliography:Application Number: CY20191100225T